• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经济模型透明度能否提高医疗服务提供者对成本效益分析的解读?回应

Can Economic Model Transparency Improve Provider Interpretation of Cost-Effectiveness Analysis? A Response.

作者信息

Cohen Joshua T, Wong John B

机构信息

*Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center †Department of Medicine, Division of Clinical Decision Making, Tufts Medical Center, Boston, MA.

出版信息

Med Care. 2017 Nov;55(11):912-914. doi: 10.1097/MLR.0000000000000811.

DOI:10.1097/MLR.0000000000000811
PMID:29028754
Abstract

To enhance the credibility and the value of health economic analyses, we argue that the computer model source code underlying these analyses should be made publicly available. Only with open publication is it possible for others to assess whether alternative assumptions, beyond those examined by the model authors, alter the model's findings. Because reproducibility is critical for scientific acceptance and because computation increasingly permeates scientific inquiry, other fields have moved toward open publication of computer models, and health economics should avoid falling behind. Making source code available shines a light on these otherwise black boxes and facilitates their complete evaluation and understandability. The preceding commentary makes 2 arguments against open publication. It claims first that open publication would undermine intellectual property rights and discourage work in this field. We respond that the impact on intellectual property would be minimal, and that open publication could even increase model value. The second argument against open publication is the possibility of model misuse. If anything, however, open publication would reduce this risk by making the model implementation completely transparent. We argue finally that open publication of models would have ancillary benefits by making the research more amenable for adaptation and innovation. Moving toward open publication will present challenges, but we believe that the benefits of increased scientific credibility and utility, particularly for health policy and clinical practice decisions, will certainly outweigh the harms.

摘要

为提高卫生经济分析的可信度和价值,我们认为应公开这些分析所基于的计算机模型源代码。只有通过公开出版,其他人才能评估除模型作者所考察的假设之外的其他假设是否会改变模型的结果。由于可重复性对于科学认可至关重要,且计算在科学探究中日益普及,其他领域已朝着计算机模型的公开出版迈进,卫生经济学应避免落后。公开源代码能让这些原本像黑匣子一样的模型暴露在阳光下,便于对其进行全面评估和理解。之前的评论提出了两条反对公开出版的理由。首先,它声称公开出版会损害知识产权并阻碍该领域的研究工作。我们回应称,对知识产权的影响将微乎其微,而且公开出版甚至可能增加模型的价值。反对公开出版的第二个理由是模型可能被滥用。然而,恰恰相反,公开出版会通过使模型实施完全透明来降低这种风险呢。我们最后指出,模型的公开出版将带来附带好处,使研究更易于被改编和创新。迈向公开出版会带来挑战,但我们相信,提高科学可信度和实用性所带来的益处,尤其是对卫生政策和临床实践决策而言,肯定会超过危害。

相似文献

1
Can Economic Model Transparency Improve Provider Interpretation of Cost-Effectiveness Analysis? A Response.经济模型透明度能否提高医疗服务提供者对成本效益分析的解读?回应
Med Care. 2017 Nov;55(11):912-914. doi: 10.1097/MLR.0000000000000811.
2
Finding Resolution for the Responsible Transparency of Economic Models in Health and Medicine.寻求医疗卫生领域经济模型责任透明度的解决方案。
Med Care. 2017 Nov;55(11):915-917. doi: 10.1097/MLR.0000000000000813.
3
Can Economic Model Transparency Improve Provider Interpretation of Cost-effectiveness Analysis? Evaluating Tradeoffs Presented by the Second Panel on Cost-effectiveness in Health and Medicine.经济模型透明度能否改善医疗服务提供者对成本效益分析的理解?对健康与医学成本效益第二小组提出的权衡进行评估。
Med Care. 2017 Nov;55(11):909-911. doi: 10.1097/MLR.0000000000000810.
4
Achieving Appropriate Model Transparency: Challenges and Potential Solutions for Making Value-Based Decisions in the United States.实现适当的模型透明度:在美国做出基于价值的决策所面临的挑战和潜在解决方案。
Pharmacoeconomics. 2019 Nov;37(11):1321-1327. doi: 10.1007/s40273-019-00832-2.
5
Transparency in Health Economic Modeling: Options, Issues and Potential Solutions.卫生经济建模中的透明度:选择、问题及潜在解决方案。
Pharmacoeconomics. 2019 Nov;37(11):1349-1354. doi: 10.1007/s40273-019-00842-0.
6
Developing Open-Source Models for the US Health System: Practical Experiences and Challenges to Date with the Open-Source Value Project.开发美国医疗体系的开源模型:开源价值项目的实践经验和当前挑战。
Pharmacoeconomics. 2019 Nov;37(11):1313-1320. doi: 10.1007/s40273-019-00827-z.
7
Procedures and methods of benefit assessments for medicines in Germany.德国药品效益评估的程序和方法。
Eur J Health Econ. 2008 Nov;9 Suppl 1:5-29. doi: 10.1007/s10198-008-0122-5.
8
Mental health care system optimization from a health-economics perspective: where to sow and where to reap?从健康经济学角度看精神卫生保健系统的优化:何处播种,何处收获?
J Ment Health Policy Econ. 2014 Jun;17(2):51-60.
9
[Procedures and methods of benefit assessments for medicines in Germany].[德国药品效益评估的程序和方法]
Dtsch Med Wochenschr. 2008 Dec;133 Suppl 7:S225-46. doi: 10.1055/s-0028-1100954. Epub 2008 Nov 25.
10
Validating Health Economic Models With the Probabilistic Analysis Check dashBOARD.使用概率分析检查仪表板验证健康经济模型。
Value Health. 2024 Aug;27(8):1073-1084. doi: 10.1016/j.jval.2024.04.008. Epub 2024 Apr 17.

引用本文的文献

1
Characterizing the Validity and Real-World Utility of Health Technology Assessments in Healthcare: Future Directions Comment on "Problems and Promises of Health Technologies: The Role of Early Health Economic Modelling".在医疗保健中描述健康技术评估的有效性和实际效用:对“健康技术的问题与前景:早期健康经济建模的作用”的评论
Int J Health Policy Manag. 2020 Aug 1;9(8):352-355. doi: 10.15171/ijhpm.2019.132.
2
Transparency in Health Economic Modeling: Options, Issues and Potential Solutions.卫生经济建模中的透明度:选择、问题及潜在解决方案。
Pharmacoeconomics. 2019 Nov;37(11):1349-1354. doi: 10.1007/s40273-019-00842-0.
3
Achieving Appropriate Model Transparency: Challenges and Potential Solutions for Making Value-Based Decisions in the United States.
实现适当的模型透明度:在美国做出基于价值的决策所面临的挑战和潜在解决方案。
Pharmacoeconomics. 2019 Nov;37(11):1321-1327. doi: 10.1007/s40273-019-00832-2.
4
The Challenge of Transparency and Validation in Health Economic Decision Modelling: A View from Mount Hood.健康经济决策模型中的透明度和验证挑战:来自胡德山的观点。
Pharmacoeconomics. 2019 Nov;37(11):1305-1312. doi: 10.1007/s40273-019-00825-1.
5
Publication of Decision Model Source Code: Attitudes of Health Economics Authors.决策模型源代码的发布:卫生经济学作者的态度
Pharmacoeconomics. 2019 Nov;37(11):1409-1410. doi: 10.1007/s40273-019-00796-3.
6
Simulation Modeling and Metamodeling to Inform National and International HIV Policies for Children and Adolescents.模拟建模和变形建模以支持国家和国际针对儿童和青少年的艾滋病毒政策。
J Acquir Immune Defic Syndr. 2018 Aug 15;78 Suppl 1(1):S49-S57. doi: 10.1097/QAI.0000000000001749.